News

 
Search

Categories

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

OUHSC Research News – Monday, December 13, 2021

OUHSC Research News – Monday, December 13, 2021

Notices and Reminders

In alignment with the University’s closure for the upcoming Winter Break, the Office of the Vice President for Research (VPR) including ORA will be closed on December 23, 2021 through December 31, 2021, reopening on January 3, 2022.

 

Any proposals or other items due to sponsors during this time must be submitted to ORA within three business days before the campus closure dates. Any contracts expiring December 31, 2021 need to be in our office by December 13, 2021. Should you need urgent assistance during the holiday closure, please contact ORA at HSCORA@ouhsc.edu. All other matters will be addressed when the University reopens for regular business hours.

 

Effective October 1st, the NIH requires all NIH-funded clinical trials to complete clinical trial registration 21 days after enrollment of first participant and/or results reporting 12 months after trial actual primary completion date.  NIH has now enhanced checks on non-compliance for these two requirements in the eRA System.  Failure to comply with NIH timeline will delay your Research Performance Progress Report (RPPR) submission.  NIH has also placed additional scrutiny on all aspects of RPPRs that has resulted in a significant increase in rejected reports from OUHSC investigators.

Because of these substantial changes and additional information requirements (including Other Support format), all RPPRs are now subject to additional review by ORA.

Effective January 1, 2022, ORA MUST receive RPPRs for review 3 business days prior to the sponsor deadline for single-project grants and 5 business days prior to the sponsor deadline for multi-project grants.

For more information on NIH enhanced checks on non-compliance, please see: https://nexus.od.nih.gov/all/2021/11/09/enhanced-checks-for-compliance-with-clinical-trial-registration-and-reporting-in-rppr/

 

We are fast approaching NIH January Deadline (i.e. January 25, 2022). Your assistance in notifying us of your intention to submit a proposal for the upcoming deadline and submitting the final proposal package according to the ORA proposal submission policy will help ensure a smooth and successful submission.

 

ORA Reminder: Effective October 1st, ORA requires applicants and recipients to use the updated Other Support format to submit with applications, Just-In-Time (JIT) and Research Performance Progress Reports (RPPRs). 

Because of the substantial changes and additional information that needs to be included, all Key Personnel on RPPRs are expected to provide Other Support in the updated format for each RPPR, regardless of when Other Support was last submitted for key personnel. Failure to follow the appropriate format on or after October 1st, may delay processing your application/award by the ORA staff.

 

ORA Reminder: As a friendly reminder, please make sure you are carefully checking PeopleSoft and the budget justification to make sure OU Norman personnel are not included in the OUHSC personnel line.  Failure to properly list the OUHSC vs Norman personnel in the budget preparation phase may result in a rebudget request from the sponsor, and could negatively impact processing of the award.

 

Requirements for Acknowledging NIH-Supported Research

NIH funded researchers are required to accurately acknowledge NIH funding in publications, press releases, or other documents about research that is funded by NIH in whole or in part. To comply with NIH requirements, recipients must include the following (as described in Communicating and Acknowledging Federal Funding):

Recipients should only acknowledge NIH awards on publications and other documents when the research activities that contributed to that publication directly arise from the award and are within the scope of the award being acknowledged. Please see the Communicating and Acknowledging Federal Funding and FAQs pages for more information on when, where, and how to acknowledge NIH funding. 

 

Interested in becoming an IRB Member?

The OUHSC Institutional Review Board (IRB) currently has openings for new IRB members.  The IRB reviews applications and reports for human research projects to ensure that the rights and welfare of human participants are protected and that risk of harm is minimized.

If you are interested in medical or social science research and would like to be involved with protecting the rights, safety and welfare of individuals who volunteer to participate in research, IRB membership may be for you.  Current members have expressed that of all the committee’s they have participated in, the IRB has been the most rewarding.  Members enjoy an increased understanding of research and exposure to cutting edge issues and current controversies in medical diagnostics and treatments.  In addition, valuable collaboration may result from working closely with board members from a variety of disciplines.

If you are interested in learning more about IRB membership, please contact the HRPP Office at 405-271-2045 or email to donna-hogan@ouhsc.edu.

 

Workshops and Seminars

Data Science Workshop

Date: December 16, 2021 at 12:00 pm

Topic: Predicting 30-day Unplanned Re-admissions at OUMC Using an XG Boost Classifier Algorithm and the scikit-learn Library in Python.

Description: The Data Science Workshop meets every third Thursday (next meeting in Dec. 16th) at noon via zoom. It is based out of OUHSC and OMRF but participation is open to anyone doing data science including scientific computing. Our talks are recorded. Seventeen past talks can be found here: (https://mediasite.ouhsc.edu/Mediasite/Channel/python). Arnold Kanagwa of OU Health He will be giving a talk about the analysis of time series data.  If you are interested in being on our mailing list and receiving the zoom link for the meeting, please contact Blaine Mooers (blaine-mooers@ouhsc.edu).

 

OUHSC Funding Opportunities

American Cancer Society Institutional Research Grant (ACS-IRG) – Underrepresented Minority Focus

Description: The ACS-IRG is a unique source of funding entrusted to Stephenson Cancer Center (SCC) that provides seed money for early-stage faculty interested in cancer-related research - the ACS has provided SCC with supplemental monies that allow support for one pilot grant specifically directed towards an underrepresented minority (URM) investigator.

Eligibility: Full time Assistant Professors within six years of their first independent faculty appointment and with no active peer-reviewed research funding from national funding agencies (e.g. NIH, DOD, NSF, ACS) may apply.

Proposals Due: January 7, 2022

Link to Full Announcement: Please refer to the attached flyer for application link and guidelines.

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu).  

  • Travere Therapeutics is seeking an academic research collaboration focused on polycystic kidney disease (ADPKD, ARPKD).  Out of scope: drug repurposing, diagnostics.  Preference is for opportunities with evidence of novel mechanism and POC data.  Submission entails a 1-pg non-confidential summary of technology (deadline 1/5).
  • A global pharmaceutical company (requested anonymity) is seeking innovative small molecule regulators of RNA transcripts that are highly selective toward their targets for treating immunologically based diseases.  Out of scope: oligotherapeutics, gene therapy approaches, viral delivery.  Submission entails a 1-pg non-confidential summary of technology (deadline 1/5).
  • Bayer Crop Science is interested in collaborating with academia to identify novel and/or engineered protein candidates that can be produced in plant cell cultures or transformed plant systems for applications in food, agriculture, sustainability, consumer health, pharmaceuticals or other industries.  Out of scope: products with a small potential market.  Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).
  • Roivant Sciences is seeking key opinion leaders/advisors to collaborate in developing a universal influenza vaccine program based on differentiated RNA technology.  Areas of interest include delivery systems for RNA, adjuvants, and modified nucleosides.  RNA-based technologies that have no potential application to respiratory diseases are out of scope.   Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).

 

NIH Notices  

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless  otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

NIH technology accelerator challenge for maternal health

Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), with the support of its partners, is offering up to $1,000,000 in cash prizes for innovative diagnostic technologies to help improve maternal health around the world.

The NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) seeks to spur and reward the development of prototypes for low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.

To win NTAC: Maternal Health, participants must: (1) Submit their design for a point-of-care diagnostic test or platform technology with initial feasibility data or references addressing at least two of the four priority conditions listed below affecting maternal health during antenatal and intrapartum periods; and (2) Submit a robust description of the proposed path for translation and further development of the diagnostic technology for use in global health settings. Additionally, diagnostics should be fully integrated digital health platforms. The four priority conditions and specific examples are as follows:

  • Infection: viral, bacterial, or parasitic infections; sepsis; post-procedural infections
  • Hypertensive disease: pre-eclampsia; eclampsia
  • Hemorrhage: acute anemia; iron deficiency anemia; coagulopathy
  • Placental issues: angiogenic or other markers of placental disruption

Proposals Due: April 1, 2022

Link to Full Announcement: https://venturewell.org/ntac/

 

Telligen Community Initiative (TCI) philanthropy - 2022 REQUEST FOR PROPOSALS

Description: Grants of up to $50,000 to Illinois, Iowa, Colorado, and Oklahoma nonprofits, schools, and agencies for programs that support creative ways to bring innovation and equity to the health sector and recruiting and generating pathways to a high-quality health care workforce. Programs can also emphasize novel approaches to positively address the social determinants of health.

All current TCI grants are for periods of one year.  Cycle 1 awardees (OK or CO) begin on June 1, 2022. 

Proposals Due: February 28, 2022

Link to Full Announcement: http://telligenci.org/grants

 

OKLAHOMA NSF EPSCoR Research Seed Grant Funding Opportunity

Description: The Oklahoma NSF EPSCoR program is announcing the availability of funding to stimulate high-risk, high-impact, and potentially transformative research to develop and test science-based solutions for complex (“wicked”) problems at the intersection of land use, water availability, and infrastructure in OK. Seed Grant proposals will be accepted by OK NSF EPSCoR from any Oklahoma institution of higher education. Funding will be awarded for projects of up to 1-year duration. The maximum award amount for a single award is $75,000; however, smaller proposals are encouraged.

Proposals Due: November 17, 2021 

Link to Full Announcement: http://www.okepscor.org/sites/default/files/u6/2022%20OK%20NSF%20EPSCoR%20Seed%20Grant%20Guidance.pdf

 

NSF Integrative Research in Biology (IntBIO)

Description: This solicitation invites submission of collaborative proposals that tackle bold questions in biology and require an integrated approach to make substantive progress. Integrative biological research spans subdisciplines and incorporates cutting-edge methods, tools, and concepts from each to produce groundbreaking biological discovery. The research should be synergistic and produce novel, holistic understanding of how biological systems function and interact across different scales of organization, e.g., from molecules to cells, tissues to organisms, species to ecosystems and the entire Earth. Such knowledge is critical to inform solutions to societal challenges, including natural resource management, resilience to environmental change, and global food security. Outcomes from integrative research will also inform and guide the development of new technologies that drive the nation's bioeconomy.

Proposals Due: January 25, 2022

Link to Full Announcement: https://www.nsf.gov/pubs/2021/nsf21622/nsf21622.htm

 

NSF Major Research Instrumentation Program: (MRI)

Description: The Major Research Instrumentation (MRI) Program serves to increase access to multi-user scientific and engineering instrumentation for research and research training in our Nation's institutions of higher education and not-for-profit scientific/engineering research organizations. An MRI award supports the acquisition or development of a multi-user research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs.

Proposals Due: January 19, 2022

Link to Full Announcement: https://www.nsf.gov/pubs/2018/nsf18513/nsf18513.pdf

 

Diabetes Research Wellness Foundation – Research Grants

Description: DRWF accepts research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. The maximum support of these grants is up to $50,000 per year for up to 2 years. If the proposed research is within an area of primary interest and is judged as having high scientific merit by the Foundation’s advisors, the Board of Directors may make special grant awards that exceed the stated maximum. Currently, the Foundation’s area of primary interest and focus are islet cell transplantation, macrovascular disease & neuropathy. All other research proposals will not be reviewed.

Proposals Due: December 30, 2021

Link to Full Announcement: https://www.diabeteswellness.net/apply-funding

 

Mary Kay Ash Foundation 2022 Cancer Research Grants

Description: The Mary Kay Ash FoundationSM is a non-profit public foundation, which focuses on funding research for innovative grants for translational research of cancers affecting women (ovarian, uterine, breast, endometrial or cervical cancer among others). Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer. The Foundation is pleased to invite your institution to submit one grant proposal. Please note only one grant application will be accepted from each accredited, invited institution.

The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period. The Foundation anticipates funding between 10 and 15 grants. Please review the attached RFP with FAQs section as well as the Applicant User Guide for additional information.

Proposals Due: February 4, 2022 at 11:59 PM (CT)

Please complete your application here: https://apply.yourcausegrants.com/apply/programs/7d085160-a542-4415-bea4-1fbe139b51ee*

 Please reach out to Julia Santosuosso if you have any questions at Julia.Santosuosso@mkcorp.com.

 

The Mselanoma Research Alliance (MRA) 2021-2022 Request for Proposal

Team Science Award Full Proposals Due (from invited applicants) Due: January 19, 2022

Description: MRA anticipates supporting at least $12.8 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Special Opportunities are also available in immunotherapy, women in research, and patient-centric clinical trials. MRA encourages applications from a diverse pool of investigators. Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP 

Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/

https://www.curemelanoma.org/research/request-for-proposals/

 

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Grant Deadline: January 28, 2022

http://www.ocascr.org/

Print

Documents to download